Rani Therapeutics Holdings, Inc. (RANI): Price and Financial Metrics

Rani Therapeutics Holdings, Inc. (RANI): $2.05

0.01 (-0.24%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add RANI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#267 of 332

in industry

RANI Price/Volume Stats

Current price $2.05 52-week high $8.75
Prev. close $2.06 52-week low $1.90
Day low $2.00 Volume 422,500
Day high $2.10 Avg. volume 550,420
50-day MA $2.34 Dividend yield N/A
200-day MA $3.61 Market Cap 109.48M

RANI Stock Price Chart Interactive Chart >


Rani Therapeutics Holdings, Inc. (RANI) Company Bio


Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-103, a glucagon-like peptide-1 mimetic to treat type 2 diabetes; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was founded in 2012 and is headquartered in San Jose, California.


RANI Latest News Stream


Event/Time News Detail
Loading, please wait...

RANI Latest Social Stream


Loading social stream, please wait...

View Full RANI Social Stream

RANI Price Returns

1-mo -13.87%
3-mo -33.22%
6-mo -53.83%
1-year 1.99%
3-year -92.18%
5-year N/A
YTD -38.25%
2023 -43.73%
2022 -63.91%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!